Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith S Currier

Showing results (51-60 of 324) with videos related to

Pageof 33
Sort By:
HIV Clinical Trials|September 24, 2016
Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot studyJordan E Lake, Sophie Seang, Theodoros Kelesidis, et al.
HIV Clinical Trials|November 29, 2007
Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and womenRisa M Hoffman, Obiamiwe C Umeh, Cindy Garris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency SyndromeSusan E Cohn, Erin Kammann, Paige Williams, et al.
AIDS Research and Human Retroviruses|January 29, 2013
Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 StudyTheodoros Kelesidis, Michelle A Kendall, Otto O Yang, et al.
Open Forum Infectious Diseases|February 23, 2019
Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral TherapyPriya Bhagwat, Shashi N Kapadia, Heather J Ribaudo, et al.
Lipids in Health and Disease|March 21, 2013
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adultsTheodoros Kelesidis, Otto O Yang, Michelle A Kendall, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|March 11, 2008
Atherosclerotic oxalosis in coronary arteriesGregory A Fishbein, Robert G Micheletti, Judith S Currier, et al.
Current HIV/AIDS Reports|January 5, 2021
Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life CourseRisa M Hoffman, Caitlin Newhouse, Brian Chu, et al.
The Journal of Infectious Diseases|October 16, 2012
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infectionTheodoros Kelesidis, Michelle A Kendall, Otto O Yang, et al.
Lipids in Health and Disease|February 25, 2011
HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDLTheodoros Kelesidis, Otto O Yang, Judith S Currier, et al.
Pageof 33

Showing results (51-60 of 324) with videos related to

Sort By:
Pageof 33
HIV Clinical Trials|September 24, 2016
Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot studyJordan E Lake, Sophie Seang, Theodoros Kelesidis, et al.
HIV Clinical Trials|November 29, 2007
Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and womenRisa M Hoffman, Obiamiwe C Umeh, Cindy Garris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency SyndromeSusan E Cohn, Erin Kammann, Paige Williams, et al.
AIDS Research and Human Retroviruses|January 29, 2013
Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 StudyTheodoros Kelesidis, Michelle A Kendall, Otto O Yang, et al.
Open Forum Infectious Diseases|February 23, 2019
Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral TherapyPriya Bhagwat, Shashi N Kapadia, Heather J Ribaudo, et al.
Lipids in Health and Disease|March 21, 2013
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adultsTheodoros Kelesidis, Otto O Yang, Michelle A Kendall, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|March 11, 2008
Atherosclerotic oxalosis in coronary arteriesGregory A Fishbein, Robert G Micheletti, Judith S Currier, et al.
Current HIV/AIDS Reports|January 5, 2021
Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life CourseRisa M Hoffman, Caitlin Newhouse, Brian Chu, et al.
The Journal of Infectious Diseases|October 16, 2012
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infectionTheodoros Kelesidis, Michelle A Kendall, Otto O Yang, et al.
Lipids in Health and Disease|February 25, 2011
HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDLTheodoros Kelesidis, Otto O Yang, Judith S Currier, et al.
Pageof 33